{
    "2019-08-28": [
        [
            {
                "time": "2018-03-15",
                "original_text": "UPDATE 1-FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients",
                "features": {
                    "keywords": [
                        "FDA",
                        "risks",
                        "AbbVie",
                        "Gilead",
                        "Merck",
                        "hepatitis C",
                        "patients"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Bristol-Myers' Empliciti Gets EMA Nod for Label Expansion",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Empliciti",
                        "EMA",
                        "label expansion"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}